The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
A rather wet and windy evening, with rain in the north and showers elsewhere.
The 19-year-old's body was discovered in Builth Wells last month, just days after he was reported missing at the Royal Welsh Show.
The funeral has taken place of a one-year-old girl who died when a parked car rolled into a wall, which then collapsed on her.